University College Hospital, Ibadan
14
2
2
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
MicroRNA Profiles in Triple Negative Breast Cancer
Role: lead
Automated Versus Manual Control Of Oxygen For Preterm Infants On Continuous Positive Airway Pressure In Nigeria
Role: collaborator
Nigerian Breast Cancer Risk-Reduction Study
Role: collaborator
The Ibadan Acute and Chronic Heart Failure Project
Role: lead
Nigeria Atrial Fibrillation Registry
Role: lead
Determinants of Access to Emergency Surgery at the University College Hospital, Ibadan
Role: lead
Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer
Role: lead
Systematic Investigation of Blacks With Stroke - GENOMICS
Role: lead
Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans
Role: collaborator
Improving Child Mental Health Service Utilization in Ibadan
Role: collaborator
Comparison of the Effectiveness of Povidone-Iodine Alone to Povidone-Iodine-Tetracycline Combination
Role: lead
Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine
Role: lead
Children's Surgery in Sub-Saharan Africa
Role: collaborator
Barriers to Care in Patients With Rectal Bleeding in Nigeria
Role: collaborator
All 14 trials loaded